Location: Greenwich, CT
CIK: 0001596452 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 6, 2024
Total Value: $236M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR S&P BIOTECH ETF | 300,000 | $29.64M | 12.5% | $98.80 | $98.25 | +0.6% | S&P BIOTECH | 78464A870 |
| LLY | ELI LILLY & CO | 14,500 | $12.85M | 5.4% | $885.93 | $283.43 | +209.8% | COM | 532457108 |
| THC | TENET HEALTHCARE | 65,000 | $10.8M | 4.6% | $166.20 | $47.80 | +247.7% | COM NEW | 88033G407 |
| NVO | NOVO-NORDISK A/S | 90,000 | $10.72M | 4.5% | $119.07 | $58.19 | +104.6% | ADR | 670100205 |
| UHS | UNIV HEALTH SVC | 45,000 | $10.3M | 4.4% | $229.00 | $132.89 | +71.5% | CLASS B | 913903100 |
| MCK | MCKESSON CORP | 20,000 | $9.888M | 4.2% | $494.40 | $290.43 | +69.3% | COM | 58155Q103 |
| SYK | STRYKER CORP | 27,000 | $9.754M | 4.1% | $361.26 | $229.84 | +55.4% | COM | 863667101 |
| BSX | BOSTON SCIENTIFIC CORPORATION | 105,000 | $8.799M | 3.7% | $83.80 | $40.22 | +108.3% | COM | 101137107 |
| ISRG | INTUITIVE SURG | 17,500 | $8.597M | 3.6% | $491.26 | $282.04 | +74.2% | COM NEW | 46120E602 |
| DHR | DANAHER CORP | 30,000 | $8.341M | 3.5% | $278.03 | $165.50 | +66.7% | COM | 235851102 |
| HCA | HCA HEALTHCARE INC | 20,000 | $8.129M | 3.4% | $406.45 | $247.21 | +62.8% | COM | 40412C101 |
| SGRY | SURGERY PARTNERS INC | 230,000 | $7.415M | 3.1% | $32.24 | $34.23 | -5.8% | COM | 86881A100 |
| ACHC | ACADIA HEALTHCRE | 115,000 | $7.292M | 3.1% | $63.41 | $68.06 | -6.8% | COM | 00404A109 |
| ABT | ABBOTT LABS | 60,000 | $6.841M | 2.9% | $114.02 * | $107.07 | +4.0% | COM | 002824100 |
| AVTR | AVANTOR INC | 250,000 | $6.468M | 2.7% | $25.87 | $23.83 | +8.6% | COM | 05352A100 |
| BDX | BECTON DICKINSON CO | 25,000 | $6.028M | 2.6% | $241.12 * | $229.54 | +2.3% | COM | 075887109 |
| BAX | BAXTER INTERNATIONAL INC. | 150,000 | $5.696M | 2.4% | $37.97 * | $37.85 | -2.0% | COM | 071813109 |
| COR | CENCORA INC | 25,000 | $5.627M | 2.4% | $225.08 | $228.58 | -2.5% | COM | 03073E105 |
| MDT | MEDTRONIC INC | 60,000 | $5.402M | 2.3% | $90.03 * | $80.83 | +7.8% | SHS | G5960L103 |
| RVTY | REVVITY INC | 40,000 | $5.11M | 2.2% | $127.75 | $117.18 | +8.7% | COM | 714046109 |
| WST | WEST PHARMACEUTICAL SERVICES INC | 17,000 | $5.103M | 2.2% | $300.18 | $350.29 | -14.6% | COM | 955306105 |
| CAH | CARDINAL HEALTH | 45,000 | $4.973M | 2.1% | $110.51 * | $70.81 | +52.8% | COM | 14149Y108 |
| SEM | SELECT MEDICAL HOLDINGS CORP | 140,000 | $4.882M | 2.1% | $34.87 * | $14.51 | +26.8% | COM | 81619Q105 |
| EHC | ENCOMPASS HEALTH CORP | 50,000 | $4.832M | 2.0% | $96.64 | $56.01 | +70.8% | COM | 29261A100 |
| VRTX | VERTEX PHARMACEUTICALS INC. | 10,000 | $4.651M | 2.0% | $465.10 | $339.24 | +37.1% | COM | 92532F100 |
| SNN | SMITH & NEPHEW | 140,000 | $4.36M | 1.8% | $31.14 | $24.98 | +24.7% | SPDN ADR NEW | 83175M205 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 40,000 | $4.318M | 1.8% | $107.95 | $107.59 | -0.9% | COM | 98956P102 |
| RGEN | REPLIGEN CORP | 25,000 | $3.721M | 1.6% | $148.84 | $151.40 | -1.7% | COM | 759916109 |
| MRVI | MARAVAI LIFESCIENCES HLDGS-A | 425,000 | $3.532M | 1.5% | $8.31 | $6.98 | +19.1% | COM CL A | 56600D107 |
| HUM | HUMANA INC. | 10,000 | $3.167M | 1.3% | $316.70 | $394.15 | -21.0% | COM | 444859102 |
| TEVA | TEVA PHARM ADR | 170,000 | $3.063M | 1.3% | $18.02 | $12.95 | +39.1% | SPONSORED ADS | 881624209 |
| STVN | STEVANATO GROUP SPA | 140,000 | $2.8M | 1.2% | $20.00 | $20.08 | -0.7% | COM | T9224W109 |
| ASND | ASCENDIS PHA-ADR | 10,000 | $1.493M | 0.6% | $149.30 | $149.30 | — | SPONSORED ADR | 04351P101 |
| — | PUT - SPY 100 @ 565 EXP 10/31/2024 | 1,500 | $861K | 0.4% | $574.00 | — | — | PUT | 99DBS2RM3 |
| — | PUT - SPY 100 @ 553 EXP 10/31/2024 | 1,300 | $746K | 0.3% | $573.85 | — | — | PUT | 99DD775M5 |